American Medical Association statement on antibody treatments

Community NewsNews
294

Translate to Spanish or other 102 languages!

We are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Image for illustration purposes.
We are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Image for illustration purposes.

Mega Doctor News

- Advertisement -

Gerald E. Harmon, M.D.
President, American Medical Association

“Given the latest data showing the Omicron variant of SARS-CoV-2 is responsible for 99% of current COVID-19 infections, we are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Limiting the use of these treatments will help ensure patients receive the best available therapy. We encourage physicians to reference the current National Institutes of Health (NIH) COVID-19 treatment guidelines for the latest information on authorized therapies and recommendations for their use.

“We continue to strongly urge every eligible individual to make sure they are up to date on their COVID-19 vaccinations, including booster doses. The Omicron variant is highly contagious and the unvaccinated remain most at risk of severe illness, hospitalization and death if infected. Data further suggests that a booster dose provides greater protection against the Omicron variant.”

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
What drives vaccine hesitancy?
Next article
Long-acting Antibody Treatment vs. Omicron Variant in Patients with Compromised Immune System

More Articles

Op-Ed: It’s Time to Rethink the Mental Healthcare Journey

When someone breaks a bone, experiences chest pain or is diagnosed with diabetes, we don't expect them to navigate a fragmented healthcare system on their own. We recognize that health conditions exist on a spectrum and that people need different levels of care at different points in their lives.

DHR Health’s Outdoor Medicine Conference Focused on Outdoor Emergency Response, Aug. 21st 

DHR Health’s Office of Continuing Medical Education will be hosting its Outdoor Medicine Conference from 1:00 to 4:00 p.m. on August 21, 2026, at the South Padre Island Convention Center, located at 7355 Padre Boulevard.

STHS Heart Introduces Advanced WATCHMAN FLX Pro Technology for Patients with Atrial Fibrilation

Atrial fibrillation (AFib), the most common type of heart rhythm disorder, is on the rise in the United States due to an aging population, increasing rates of obesity and high blood pressure and the growing use of wearable devices that can detect irregular heartbeats. 

Salmonella Outbreak Linked to Shell Eggs

CDC, FDA, and public health officials in several states are investigating a multistate outbreak of Salmonella infections linked to shell eggs. If you have recalled shell eggs in your home or business, throw them out or return them
- Advertisement -